People

Dr. Harry Dawson has the role of Scientific Project Manager and researcher at Cherry Biotech to assist in external scientific project management and internal R&D development. Harry completed an MSc in Biomedical Engineering in Paris, focused on biomaterials and microfluidic systems. From this, he completed a PhD CIFRE project with the pharmaceutical company MedinCell to develop high-throughput microfluidic systems for drug development. During this time, he also completed an MBA specializing in innovation management in varying sized companies.

In this role, research priorities are focussed on product development, platform characterisation and prototyping of novel applications using the technology developed at Cherry Biotech. The company aim is to develop a standardised organ-on-chip (OOC) platform that can be integrated into exisitng academic and industrial workflows to control media enrichment, temperature and model shear stress (among other biophysical parameters). Within the PLAST CELL project, this research is being used to develop an industrially compatible approach for cell confinement that can remain low-cost, highly reproducible and simple to integrate with existing academic / pharmaceutical laboratoires.